FSD Pharma Inc., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. FSD Pharma Inc. is headquartered in Toronto, Canada.
Frequently asked questions
What sector does FSD Pharma Inc (HUGE) operate in?
FSD Pharma Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is FSD Pharma Inc (HUGE) current stock price?
As of the latest data, FSD Pharma Inc stock price is CA$7.47, with a previous close of CA$7.47.
What is FSD Pharma Inc (HUGE) current market capitalization?
FSD Pharma Inc market cap is approximately 5.29 million.
What is FSD Pharma Inc (HUGE) Earnings Per Share (EPS)?
The trailing EPS is -CA$22.28.
Does FSD Pharma Inc (HUGE) pay dividends?
No. FSD Pharma Inc does not pay a dividend.
What is FSD Pharma Inc (HUGE) beta (volatility) score?
FSD Pharma Inc has a beta of 0.848, meaning its volatility is roughly in line with the market.
